ImmunityBio, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
ImmunityBio, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2014 to Q3 2024.
  • ImmunityBio, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$85.7M, a 10.3% increase year-over-year.
  • ImmunityBio, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$588M, a 28.3% decline year-over-year.
  • ImmunityBio, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$583M, a 40% decline from 2022.
  • ImmunityBio, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$417M, a 20.1% decline from 2021.
  • ImmunityBio, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$347M, a 56.3% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$588M -$85.7M +$9.85M +10.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$598M -$135M +$3.32M +2.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 -$601M -$134M -$17.8M -15.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$583M -$233M -$125M -116% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-19
Q3 2023 -$458M -$95.6M +$15.4M +13.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$473M -$138M -$43.3M -45.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 -$430M -$116M -$13.5M -13.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$417M -$108M -$17M -18.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-19
Q3 2022 -$400M -$111M -$23.3M -26.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$376M -$94.6M -$6.3M -7.14% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$370M -$103M -$23.2M -29.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$347M -$91.3M -$59.1M -184% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-19
Q3 2021 -$288M -$87.6M -$22M -33.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$266M -$88.3M -$36.8M -71.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$229M -$79.6M -$42.6M -115% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$186M -$32.1M -$16.5M -105% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-04
Q3 2020 -$170M -$65.6M -$50M -321% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$120M -$51.4M -$34.8M -208% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$84.9M -$37M -$19.2M -107% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$65.8M -$15.6M +$1.7M +9.8% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-04
Q3 2019 -$67.5M -$15.6M +$8.05M +34.1% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-04
Q2 2019 -$75.5M -$16.7M +$11.1M +39.8% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-04
Q1 2019 -$86.6M -$17.9M +$9.63M +35% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-04
Q4 2018 -$96.2M -$17.3M +$7.15M +29.2% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-25
Q3 2018 -$103M -$23.6M +$334K +1.39% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-25
Q2 2018 -$104M -$27.7M -$4.28M -18.3% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-25
Q1 2018 -$99.4M -$27.5M -$3M -12.3% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-25
Q4 2017 -$96.4M -$24.5M -$249K -1.03% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-13
Q3 2017 -$96.2M -$24M +$7.93M +24.9% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-13
Q2 2017 -$104M -$23.5M +$10.5M +31% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-13
Q1 2017 -$115M -$24.5M +$6.16M +20.1% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-13
Q4 2016 -$121M -$24.2M +$2.58M +9.63% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-12
Q3 2016 -$123M -$31.9M +$14.4M +31.1% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-12
Q2 2016 -$138M -$34M +$96.9M +74% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-12
Q1 2016 -$235M -$30.7M +$2.17M +6.61% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-12
Q4 2015 -$237M -$26.8M -$24.1M -874% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-15
Q3 2015 -$213M -$46.3M -$45.4M -4945% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-15
Q2 2015 -$167M -$131M -$129M -9098% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-15
Q1 2015 -$37.9M -$32.8M -$31.8M -2916% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-15
Q4 2014 -$6.19M -$2.76M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 -$918K Jul 1, 2014 Sep 30, 2014 10-K 2016-03-30
Q2 2014 -$1.42M Apr 1, 2014 Jun 30, 2014 10-K 2016-03-30
Q1 2014 -$1.09M Jan 1, 2014 Mar 31, 2014 10-K 2016-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.